Thomas Slaney

Bristol-Myers Squibb Company

Thomas Slaney is a Senior Scientist I in the Biologics Development and Attribute Sciences department within Bristol Myers Squibb, where he specializes in LC-MS protein characterization to support early to late stage development. His current research includes elucidating mechanisms of protein translation errors in biotherapeutic manufacturing, identifying unusual post-translational modifications in cell lines, and improving sensitivity for detection of host-cell protein impurities. Prior to joining BMS, he received his Ph.D. in Analytical Chemistry from University of Michigan in 2013, working in the laboratory of Prof. Robert Kennedy. Thomas also completed a post-doctoral fellowship at Boehringer Ingelheim in Ridgefield, CT and Biberach, Germany, developing microsampling LC-MS bioanalytical methods for pre-clinical studies.